Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004930470 | SCV005593931 | uncertain significance | not specified | 2024-09-30 | criteria provided, single submitter | clinical testing | The p.T330K variant (also known as c.989C>A), located in coding exon 5 of the GALNT12 gene, results from a C to A substitution at nucleotide position 989. The threonine at codon 330 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |